Assessment of Fatty Liver with Thermo-acoustic Device

Launched by MEDICAL COLLEGE OF WISCONSIN · Mar 6, 2020

Keywords

ClinConnect Summary

This clinical trial is looking at a new way to assess fatty liver disease using a special type of ultrasound called thermo-acoustic ultrasound. Researchers want to see how accurately this device can estimate the amount of fat in the liver compared to a standard imaging test known as MRI-PDFF. They are also testing how well this device can detect fatty liver conditions, including non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).

To join the study, participants should be between 18 and 70 years old and either have been diagnosed with or are suspected of having fatty liver disease. They must be able to understand and sign a consent form and be able to undergo ultrasound and MRI tests. However, people with certain medical devices, such as pacemakers, or those who are pregnant or unable to tolerate these tests cannot participate. If eligible, participants can expect to undergo both ultrasound and MRI scans during the trial to help researchers gather important data about fatty liver disease.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • patients diagnosed or suspected to have non-alcoholic fatty liver disease
• • Patients 18-70 years of age
• • be able to understand and sign on written informed consent
• • able to undergo ultrasound and MRI examinations
• Exclusion Criteria:
• • any metal or electronic implants including but not limited to pacemakers, clips, hips
• • known history of pregnancy or becoming pregnant during study period
• • unable to understand and sign on written informed consent
• • intolerant to ultrasound and/or MRI examinations